Lourdes G. Planas, RPh, PhD, FAPhA
Associate Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47294
Fax (405) 271-6430
Office CPB 243
Email Lourdes-Planas@ouhsc.edu
Summary
Dr. Planas teaches biostatistics, drug literature evaluation, and sociobehavioral aspects of medication use. She uses qualitative and quantitative research methods to assess medication optimization interventions in community pharmacy and primary care practice settings. She works with Latinx and other underserved communities to advance health literacy and patient engagement in cardiovascular health, diabetes, and vaccinations. Dr. Planas has conducted scholarship of teaching and learning on the development of problem-solving and communication skills among student pharmacists.
Publications & Presentations
- 1. Zelnicek T D, Sewell H E, Planas L G, Skaggs J C, Lim J, Johnson C E, O'Neal K S. Assessing current knowledge of hearing impairment with diabetes by surveying providers with CBDCE certification. Sci Diabetes Self Manag Care. In Press
2. Planas L G, Unni E J, Barner J C, Thomas T F, Devraj R, Quiñones-Boex A C, Blakely M L, Clark M A, Irwin A N, Moore T S, Nagel-Edwards K, Suda K J, Zgarrick D, Young H N, Nau D P, Warholak T. Gender equity perceptions among social and administrative sciences pharmacy faculty: an AACP-APhA task report. Am J Pharm Educ. 2024; 88(11) : 101301.
3. Ogunsanya M E, Wagner J L, Bennett K, Medina M S, Starnes S, Planas L G. Debate as an active learning pedagogy among pharmacy students in a public health course. Am J Pharm Educ. 2024; 88(7) : 100724.
4. Sewell H E, Planas L G, Brown Jr M R, Orcutt N, Johnson C E, Lim J, Skaggs J C, O'Neal K S. Diabetes and hearing impairment: Knowledge, attitudes, and practices among providers and patients. Sci Diabetes Self Manag Care. 2024; 50(3) : 201-210.
5. Sifat M, Hébert E T, Ahluwalia J S, Businelle M S, Frank-Pearce S, Bryer C, Benson L, Madison S, Planas L G, Baranskaya I, Kendzor D E. Varenicline Combined With Oral Nicotine Replacement Therapy and Smartphone-Based Medication Reminders for Smoking Cessation: Feasibility Randomized Controlled Trial. JMIR Form Res. 2023; 7 : e48857.
Grants
- 1. Addressing opioid use disorder in older adults through primary care innovation. AHRQ. Start Date: 2020. End Date: 2024.
2. Diabetes and hearing impairment: Knowledge, attitudes, and practices among providers and patients. ASHP. Start Date: 2022. End Date: 2023.
3. A comparison of the effectiveness of combination varenicline and oral nicotine replacement therapy versus varenicline alone for smoking cessation: A pilot study. PhRMA. Start Date: 2018. End Date: 2020.
4. Reducing opioid prescribing through education and support (ROPES-3). NIH. Start Date: 2018. End Date: 2019.
5. Exploration of Oklahoma pharmacist involvement in the ABCS of cardiovascular dsease and stroke prevention. Start Date: 2012. End Date: 2013.
Awards and Honors
- 16. Phi Lambda Sigma, OU College of Pharmacy Faculty Leadership Award. Date: 2007.
17. American Association of Colleges of Pharmacy Honorable Mention, Innovations in Teaching Competition. Date: 2007.
18. American Foundation for Pharmaceutical Education. Pre-Doctoral Fellow. Date: 1998.
19. SmithKline Beecham Pharmaceuticals Superior Achievement in Clinical Pharmacy. Date: 1990.
Education
- 1. Degree: Ph D. University of Florida. Date: 2001.
2. Degree: BS. Xavier University of Louisiana. Date: 1990.
Administrative Assignments
no results